RLAY Latest Headlines

Guggenheim Sticks to Its Buy Rating for Relay Therapeutics (RLAY)

at www.tipranks.com (Fri, 13-Mar 7:57 AM)

Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Stryker (SYK) and Elutia (ELUT)

at www.tipranks.com (Thu, 12-Mar 9:10 AM)

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Relay Therapeutics (RLAY)

at www.tipranks.com (Thu, 12-Mar 7:01 AM)

Relay Therapeutics Updates Bylaws on Federal Securities Litigation

at www.tipranks.com (Wed, 11-Mar 9:21 PM)

Relay Therapeutics Poised for Impact as Biliary Tract Cancer Market Set for 10.1% CAGR Growth Through 2034

Market Chameleon (Tue, 3-Mar 7:42 AM)

Relay Therapeutics Outlines Major 2026 Milestones as Cash Reserves Remain Robust and Clinical Data Builds Momentum

Market Chameleon (Fri, 27-Feb 11:52 AM)

Relay Therapeutics Sets Stage for Major Clinical Milestones in 2026 on Solid Financial Ground

Market Chameleon (Fri, 27-Feb 8:59 AM)

Relay Therapeutics Sets Financial Results Date as Phase 3 Trials on Zovegalisib Progress

Market Chameleon (Fri, 20-Feb 8:40 AM)

FDA Breakthrough Therapy Designation Positions Relay’s Zovegalisib as Potential Game-Changer for Advanced Breast Cancer

Market Chameleon (Tue, 3-Feb 7:38 AM)